Gene therapy has great potential as a treatment for many human diseases by the transfer of therapeutic genes to cells. However, the lack of safe and efficient gene carrier systems is one of the primary limiting obstacles for the introduction of gene therapy into practical medicine. Current research focuses on two possible gene carrier systems: virus-based ( viral ) and non-viral vectors. While viral vectors have extremely high gene delivery performance, they carry a risk of causing adverse reactions. Non-viral vectors, in particular those formulated using synthetic polymers, have attracted the interest of an increasing number of researchers as safer alternatives that carry a greatly reduced risk of the adverse reactions that have plagued th...